ConAgra Brands
CAG , maker of Marie Callender's, Healthy Choice, Birds Eye, Orville Redenbacher's, Slim Jim, and many more, has seen a continuous drop in share price since the rise of interest rates, inflation, and tariffs. The stock is currently trading near its book value of $18.71 and has a dividend yield of 6.9%. Debt-to-equity is reasonable (0.9x), but the company does have a Quick Ratio of 0.2x (short-term liquidity issues) and a Altman's Z Score (bankruptcy risk) of 1.7, which should ideally be 3+. Like almost every large-scale food company, earnings growth is relatively low, but 2025 is anticipated to be its worst performing year - which explains the price.
While the stock is not likely to generate triple-digit returns in the near-term,
CAG is a strong company with a nice dividend and some growth ahead. I foresee such stocks getting new life with drops interest rates. However, a dip near $17 (into my "crash" simple moving average area) or even slightly lower is possible - which may likely result in another stock entry.
Thus, at $19.38,
CAG is in a personal buy-zone with future entries planed near $17 or below.
Targets into 2028
While the stock is not likely to generate triple-digit returns in the near-term,
Thus, at $19.38,
Targets into 2028
- $22.00 (+$13.5%)
- $25.00 (+29.0%)
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.